1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Larysa Sanchez: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse Talquetamab, Daratumumab - Multiple Myeloma in Relapse | Phase 2 | Recruiting | Larysa Sanchez | 23 | 2025-11-18 | 2026-09-14 |
| Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM Daratumumab, Bortezomib, Lenalidomide - Newly Diagnosed Multiple Myeloma | Phase 2 | Completed | Larysa Sanchez | 20 | 2019-10-24 | 2026-10-07 |
Multiple Myeloma (2) · Neoplasms, Plasma Cell (1) · Recurrence (1)
daratumumab (2) · Bortezomib (1) · Dexamethasone (1) · Lenalidomide (1) · ixazomib (1) · talquetamab (1)
United States (2)